"Another Hospital Tried the Procedure and Gave Up — They Told Us He Needed a Heart Transplant." He Was 58. End-Stage Heart Failure. An Ejection Fraction of 25%. Venous Anatomy Too Complex for Any Other Center to Navigate. One Last Hope.
Mr. Zhang had always been the kind of man who took care of everyone else.
A 58-year-old former logistics manager, he had spent three decades keeping things moving — coordinating, problem-solving, showing up. He was the person his family called when something needed fixing. He was the grandfather who walked his grandchildren to school every morning, who carried the groceries, who never sat still long enough to be called old.
Then, over the course of a single year, everything changed.
The breathlessness came first — climbing stairs, then walking across a room, then simply standing up from a chair. Then the swelling in his legs. Then the nights spent sitting upright because lying flat made him feel like he was drowning. His wife watched him shrink from the man she knew into someone who could not cross the apartment without stopping to rest.
The diagnosis was dilated cardiomyopathy with end-stage heart failure. His heart — enlarged, weakened, and electrically disorganized — was pumping at a fraction of its normal capacity. His Left Ventricular Ejection Fraction (LVEF) was 25%. A healthy heart pumps at 55% or above. His ECG showed a Left Bundle Branch Block (LBBB): the electrical signal that coordinates the contraction of his heart's walls was misfiring, causing the chambers to contract out of sequence, wasting what little pumping power remained.
His doctors had tried everything available to them. Beta-blockers. ACE inhibitors. Diuretics. Maximum medical therapy. His condition continued to deteriorate. He was classified as NYHA Class IV — the most severe category of heart failure, defined by an inability to perform any physical activity without discomfort. He was, in the clinical language of cardiology, bedbound.
The next step was a specialized pacemaker — a Cardiac Resynchronization Therapy device (CRT) — designed to correct the electrical dyssynchrony and give the heart muscle a chance to recover. A center attempted the procedure. They navigated toward the coronary sinus — the venous channel through which the left ventricular lead must be threaded — and encountered anatomy too tortuous, too complex, to proceed safely. The procedure was aborted. The family was told that Mr. Zhang's options had run out. That the next conversation would be about a heart transplant.
Mr. Zhang's daughter would not accept that. She had watched her father take care of everyone around him for her entire life. She was not ready to stop looking for someone who could take care of him.
Determined to find a cardiologist who would not give up, the family traveled to Shanghai and sought care from Dr. Ge Junbo, Director of Cardiology at Zhongshan Hospital, Fudan University, and Academician of the Chinese Academy of Sciences, through China Medical Concierge – Shanghai (CMCS).
Understanding Heart Failure and Cardiac Resynchronization: Why Specialist Expertise Is Everything
Heart failure is not a single disease — it is a syndrome in which the heart's ability to pump blood is insufficient to meet the body's demands. In dilated cardiomyopathy, the heart muscle weakens and the chambers enlarge, reducing contractile force. When this is compounded by electrical dyssynchrony — as in Left Bundle Branch Block — the already-compromised heart wastes energy contracting its walls out of sequence, accelerating deterioration. Cardiac Resynchronization Therapy is one of the most evidence-based interventions in modern cardiology, but its delivery in complex cases demands a level of expertise that is not universally available:
- Cardiac Resynchronization Therapy (CRT) can reverse heart failure — but only with precise lead placement — CRT works by delivering carefully timed electrical impulses to both ventricles simultaneously, restoring coordinated contraction and dramatically improving cardiac efficiency; the therapeutic benefit depends entirely on placing the left ventricular lead at the optimal site — typically the lateral or posterolateral wall of the left ventricle — and avoiding scar tissue that will not respond to pacing; suboptimal lead position is the leading cause of CRT non-response
- Complex coronary sinus anatomy is the primary technical barrier to CRT success — the left ventricular lead must be delivered through the coronary sinus, a venous structure that varies enormously between patients in its branching pattern, caliber, and angulation; tortuous, stenotic, or unfavorably oriented veins can make lead delivery impossible with standard tools, and the risk of coronary sinus dissection — a serious complication — rises sharply with anatomical complexity; centers without advanced tools and high procedural volume frequently abort the procedure in these cases
- 3D electro-anatomic mapping transforms complex CRT implantation — advanced mapping systems allow the electrophysiology team to construct a three-dimensional model of the heart's electrical activation sequence, identifying the latest-activating segment — the optimal pacing target — and distinguishing viable myocardium from scar tissue that will not respond to resynchronization; this technology converts a procedure that would otherwise be guided by anatomy alone into one guided by both anatomy and electrical physiology
- Left Bundle Branch Block is the strongest predictor of CRT response — patients with LBBB and a wide QRS complex derive the greatest benefit from CRT, with studies demonstrating ejection fraction improvements of 10–15 percentage points and dramatic reductions in heart failure hospitalization and mortality; Mr. Zhang's LBBB made him an ideal candidate for CRT — if the lead could be placed
- Cardiac reverse remodeling is the goal — and it is achievable — when CRT successfully resynchronizes the heart, the myocardium undergoes reverse remodeling: the dilated chambers shrink, wall motion improves, and ejection fraction rises; this is not merely symptomatic improvement — it represents a genuine structural recovery of the heart muscle, reducing long-term mortality and the risk of sudden cardiac death
- CRT-D combines resynchronization with defibrillation protection — patients with severely reduced ejection fraction are at elevated risk of life-threatening ventricular arrhythmias; a CRT-D device adds an implantable defibrillator to the resynchronization function, providing a safety net against sudden cardiac death while the heart undergoes the recovery process
About Dr. Ge Junbo 葛均波
Dr. Ge Junbo is the Director of the Department of Cardiology at Zhongshan Hospital, Fudan University and an Academician of the Chinese Academy of Sciences — the highest academic honor in Chinese science. One of the most influential cardiologists in Asia, Dr. Ge bridges the gap between cutting-edge cardiovascular research and frontline clinical practice. Internationally recognized for his contributions to interventional cardiology and heart failure management, he leads China's national initiative for Standardized Heart Failure Management and has authored or co-authored the clinical guidelines that define the standard of care for heart failure across the country. For patients who have exhausted the options available at other centers, Dr. Ge's department — a designated National Heart Failure Center — represents the highest level of cardiac expertise available in China.
His clinical expertise spans:
- Complex Cardiac Resynchronization Therapy (CRT/CRT-D) implantation — advanced CRT procedures for patients with difficult venous anatomy, prior failed implantation attempts, and high-risk profiles, utilizing 3D electro-anatomic mapping and specialized delivery systems to achieve optimal left ventricular lead placement
- Comprehensive heart failure management — multidisciplinary, guideline-directed medical therapy and device-based treatment for heart failure with reduced ejection fraction (HFrEF), including optimization of pharmacological therapy, CRT, and implantable cardioverter-defibrillator (ICD) implantation
- Complex interventional cardiology (PCI) — percutaneous coronary intervention for complex coronary artery disease, including chronic total occlusions, left main disease, and multivessel disease in high-risk patients
- Structural heart disease — transcatheter and hybrid approaches to valvular heart disease and other structural cardiac conditions
- Electrophysiology and device therapy — implantation and optimization of pacemakers, ICDs, and CRT devices, including hemodynamic optimization of AV and VV intervals post-implantation
- National heart failure program leadership — design and implementation of standardized heart failure management protocols across China's National Heart Failure Center network, ensuring evidence-based care reaches patients at every level of the healthcare system
The Case That Proved "No More Options" Was Not the Final Answer
The Situation
A 58-year-old man. End-stage heart failure secondary to dilated cardiomyopathy. LVEF of 25%. Left Bundle Branch Block with wide QRS, confirming electrical dyssynchrony. Maximum medical therapy exhausted with continued deterioration. NYHA Class IV — bedbound, unable to perform any physical activity without discomfort. A prior CRT implantation attempt aborted due to complex coronary sinus anatomy. A family told that the next step was a heart transplant. One question: is there a cardiologist who has the tools, the team, and the experience to place a lead where no one else could — and give this heart a chance to recover?
The Assessment
Dr. Ge reviewed Mr. Zhang's complete imaging — echocardiograms, ECGs, the procedural records from the prior failed attempt, and CT venography of the coronary sinus anatomy. He studied the branching pattern of the lateral veins, the angulation of the coronary sinus ostium, and the distribution of viable myocardium versus scar tissue on the echocardiographic strain maps. His assessment was precise: the anatomy was difficult — genuinely difficult — but it was not impossible. The prior team had lacked the specialized tools and the mapping technology to navigate it safely. His team did not.
He explained his approach to the family with the directness of a clinician who has had this conversation many times:
"Heart failure is not just a pump problem; it is an electrical and structural problem. We must correct the synchrony to give the heart muscle a chance to recover. The goal of modern cardiology is not just to keep the patient alive, but to restore their dignity and function. If we can resynchronize the heart before irreversible damage occurs, we can reverse the course of the disease. Our job is to push the boundaries of what is technically possible to give every patient that chance."
He told them what the procedure would involve, what the risks were, and what a successful outcome could look like. He did not promise a miracle. He offered a plan — and the expertise to execute it.
The Procedure
Dr. Ge led a specialized electrophysiology and heart failure team in a Complex CRT-D Implantation — Cardiac Resynchronization Therapy combined with an implantable defibrillator.
Before a single lead was placed, the team deployed a 3D electro-anatomic mapping system to construct a detailed model of Mr. Zhang's heart — mapping the electrical activation sequence across the left ventricle, identifying the latest-activating segment (the optimal pacing target), and delineating the areas of scar tissue to be avoided. The map transformed the procedure from an anatomical challenge into a precisely defined target.
Navigating the tortuous coronary sinus anatomy that had defeated the prior team, Dr. Ge's electrophysiologists used specialized sheaths and stylets — tools selected specifically for the angulation and caliber of Mr. Zhang's venous anatomy — to advance through the coronary sinus without causing dissection. The left ventricular lead was threaded into a lateral vein, positioned at the site identified by the mapping system as the latest-activating segment of the myocardium. True biventricular pacing was confirmed. The right ventricular and right atrial leads were placed. The defibrillator was connected.
Immediately after device activation, Dr. Ge's team performed hemodynamic optimization — adjusting the AV interval (the timing between atrial and ventricular activation) and the VV interval (the timing between right and left ventricular activation) to maximize cardiac output. The optimization was guided by real-time hemodynamic measurements, not by default device settings. Mr. Zhang's blood pressure stabilized on the table.
The Recovery
Three months after the procedure, Mr. Zhang returned to Zhongshan Hospital for his follow-up echocardiogram.
His LVEF had risen from 25% to 42%.
In cardiology, this is called reverse remodeling — the heart, freed from the burden of electrical dyssynchrony, had begun to recover its structure. The dilated chambers had contracted. The wall motion had improved. The muscle that had been wasting its effort contracting out of sequence was now working in coordinated, efficient unison. His NYHA classification moved from Class IV to Class II — from bedbound to functional, from unable to cross a room to able to walk his neighborhood.
In the year that followed, Mr. Zhang had zero heart failure hospitalizations.
His daughter called CMCS on the morning he walked his grandchildren to school for the first time in two years. She did not have many words. She said: "He's back."
Outcome Summary
- ✅ Complex CRT-D successfully implanted — left ventricular lead placed in the optimal lateral vein position using 3D electro-anatomic mapping and specialized delivery tools, in a patient whose prior implantation attempt had been aborted due to anatomical complexity
- ✅ Ejection fraction improved from 25% to 42% — cardiac reverse remodeling confirmed at three-month follow-up echocardiogram, representing a 17-percentage-point improvement in left ventricular function
- ✅ NYHA Class IV to Class II — Mr. Zhang progressed from bedbound and unable to perform any physical activity without discomfort to walking independently, caring for his grandchildren, and managing daily activities without limitation
- ✅ Zero heart failure hospitalizations in the first year — complete elimination of heart failure-related hospital admissions in the twelve months following CRT-D implantation
- ✅ Immediate hemodynamic stabilization — blood pressure stabilized on the table following device activation and AV/VV interval optimization, confirming effective resynchronization from the first moment of biventricular pacing
- ✅ World-class outcome at a fraction of the cost — complex CRT-D implantation in Shanghai at a fraction of US costs, with mapping technology, procedural expertise, and post-implantation optimization that exceeded what had been available — or attempted — abroad
"He was 58. End-stage heart failure. An ejection fraction of 25%. Another center had tried to implant the device and given up — the anatomy was too complex. They told his family he needed a heart transplant. Dr. Ge Junbo at Zhongshan Hospital, Fudan University led a specialized team using 3D mapping and precision tools to place the lead where no one else could. Three months later, Mr. Zhang's ejection fraction had risen to 42%. He was walking his grandchildren to school again."
Why Shanghai for Heart Failure and CRT Treatment?
- World-class outcomes at a fraction of the cost — complex CRT implantation and comprehensive heart failure management in Shanghai costs a fraction of what it would in the US, with access to the same mapping technologies, device platforms, and evidence-based protocols used at the world's leading cardiac centers, without the prohibitive costs or the waiting lists
- National Heart Failure Center designation — Zhongshan Hospital's cardiology department is a designated National Heart Failure Center, operating under the standardized management protocols developed and led by Dr. Ge Junbo; this designation reflects the department's infrastructure, multidisciplinary team depth, and outcomes data across the full spectrum of heart failure complexity
- 3D electro-anatomic mapping as standard for complex CRT — advanced mapping technology that transforms complex CRT implantation from an anatomical challenge into a precisely guided procedure is not universally available; at Zhongshan Hospital, it is standard practice for high-risk and previously failed cases, enabling successful lead placement in patients who have been turned away elsewhere
- Multidisciplinary heart failure team approach — Dr. Ge's department operates as a true multidisciplinary team, integrating cardiology, electrophysiology, cardiac imaging, and heart failure nursing into a coordinated management program; treatment decisions are made collectively, not by a single physician, ensuring that every patient receives the full benefit of the team's combined expertise
- Academic leadership translating directly into clinical outcomes — Dr. Ge's role as an author of China's national heart failure guidelines means that his department's practice is not merely aligned with international evidence — it helps define it; patients treated by Dr. Ge's team receive care that reflects the current frontier of cardiovascular medicine
How CMCS Supports International Patients Seeking Heart Failure Treatment in Shanghai
- 🏥 Specialist access — direct connection to Dr. Ge Junbo and Zhongshan Hospital's Department of Cardiology and National Heart Failure Center, including priority appointment coordination for patients with urgent or complex presentations
- 📋 Echocardiograms, ECGs, cardiac CT, prior procedural records, and medication history translation & coordination
- 🗣️ On-site medical interpretation at every consultation, procedure, and follow-up
- ✈️ Travel & logistics coordination — visa, accommodation, airport transfers
- 📞 24/7 concierge support from first inquiry through every stage of treatment
- 🔄 Post-treatment follow-up — device clinic coordination, echocardiographic monitoring scheduling, heart failure medication optimization support, and long-term cardiac rehabilitation coordination
📢 Subscribe to China Medical Concierge – Shanghai (CMCS)
We're delighted to offer you trusted medical tourism and personalized medical concierge services, giving you and your loved ones an extra pathway to quality care from China.
💬 Got questions? Drop a comment or DM us — we're always here to help!
📢 Have your own incredible medical story in China? Share it with us in the comments below!
#ChinaMedicalTour #AffordableHealthcare #MedicalTourismChina #ChinaHealthcare #MedicalConcierge #HeartFailure #CardiacResynchronization
🤝 Connect With CMCS
Struggling with long medical waitlists? Facing barriers to overseas treatment? China Medical Concierge – Shanghai (CMCS) helps international patients access premium medical care in Shanghai's top public & private hospitals, with end-to-end personalized support.
Contact us for international patient support:
📧 contract@medicalsh.com | 🌐 medicalsh.com
0件のコメント